| US 7,371,725 B2 | ||
| Spondyloarthropathies | ||
| Frank Luyten, Kraainem (Belgium); and Rik Lories, Linden (Belgium) | ||
| Assigned to K.U. Leuven Research & Development, Leuven (Belgium) | ||
| Appl. No. 10/503,751 PCT Filed Feb. 05, 2003, PCT No. PCT/BE03/00018 § 371(c)(1), (2), (4) Date Aug. 05, 2004, PCT Pub. No. WO03/066081, PCT Pub. Date Aug. 14, 2003. |
||
| Claims priority of application No. 0202625.0 (GB), filed on Feb. 05, 2002. | ||
| Prior Publication US 2005/0106144 A1, May 19, 2005 | ||
| Int. Cl. A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01) | ||
| U.S. Cl. 514—12 [514/2; 514/8] | 4 Claims |
| 1. A method for reducing the incidence of or treating Spondyloarthropathic (SpA) enthesitis in a mammal comprising the step of administering to said mammal an amount of noggin effective to reduce the incidence of or to treat SpA enthesitis. |